Evidence map›Paper›PMID 35955355›Full record

ArticleMaterials (Basel, Switzerland)2022

Effects of 5 wt.% Polycaprolactone, Polyhydroxybutyrate and Polyvinyltrimethoxysilane on the Properties of Ag/Zn/Mg Alloy.

Marzieh Rabiei, Motahareh Sadat Raziyan, Reza Ebrahimi-Kahrizsangi, Sohrab Nasiri, Arvydas Palevicius, Giedrius Janusas, Andrius Vilkauskas

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marzieh RabieiFaculty of Mechanical Engineering and Design, Kaunas University of Technology, LT-51424 Kaunas, Lithuania.ORCID 0000-0003-0393-1946
Motahareh Sadat RaziyanFaculty of Mechanical Engineering and Design, Kaunas University of Technology, LT-51424 Kaunas, Lithuania.
Reza Ebrahimi-KahrizsangiAdvanced Materials Research Center, Department of Materials Engineering, Najafabad Branch, Islamic Azad University of Najafabad, Najafabad P.O. Box 85141-43131, Iran.ORCID 0000-0002-0388-2980
Sohrab NasiriFaculty of Mechanical Engineering and Design, Kaunas University of Technology, LT-51424 Kaunas, Lithuania.
Arvydas PaleviciusFaculty of Mechanical Engineering and Design, Kaunas University of Technology, LT-51424 Kaunas, Lithuania.ORCID 0000-0003-1226-062X
Giedrius JanusasFaculty of Mechanical Engineering and Design, Kaunas University of Technology, LT-51424 Kaunas, Lithuania.ORCID 0000-0002-1055-2568
Andrius VilkauskasFaculty of Mechanical Engineering and Design, Kaunas University of Technology, LT-51424 Kaunas, Lithuania.

Funding

Lietuvos Mokslo Taryba 09.3.3-LMT-K-712-23-0156
6 · The paper itself

Abstract

Mg-based alloys have several suitable properties for biomaterials, but they have major problems of being less antibacterial and have a low mechanical strength. To solve these problems, a new combination of Ag/Zn/Mg was prepared in this study, where the presence of Zn and Ag can help to increase the bioactivity. The use of 5 wt.% polymers consisting of PolyCaproLactone (PCL), PolyHydroxyButyrate (PHB) and PolyVinylTriMethoxySilane (PVTMS) is also investigated. DSC, XRD, TEM, FTIR, SEM, and EDAX analysis, as well as mechanical and bioactive behavior, were investigated to characterize the prepared composites. In the comparison, the best behavior was found when PHB was used. The results show that the strength values ranged from ~201 to 261 MPa.

Indexed as

Ag/Zn/Mg alloybioactivitymechanical propertiesPolyCaproLactonePolyHydroxyButyratePolyVinylTriMethoxy-Silane

Identifiers

PMID35955355
PMCPMC9369843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.